IL6 and neoplasm: M2d macrophages, also referred to as tumor-associated macrophages, are driven by Toll-like receptor ligands, IL-6, and adenosine receptor activation, and contribute to angiogenesis and tumor progression by releasing TGF-β, IL-10, and vascular endothelial growth factor (VEGF) [76].